Medical Yoga for Patients With Stress-related Symptoms

Not Applicable

Completed

• Conditions: Stress-related Illness/Anxiety
• Interventions: Other: Medical Yoga; Other: Treatment as Usual (physical therapy)

• Registration Number: NCT02907138
• Lead Sponsor: Maria Larsson

Brief Summary

The purpose of this study is to compare the effect of Medical Yoga as a group treatment, to conventional treatment provided by a physical therapist, for people with perceived stress-related symptoms.

Forty people are to be randomized to either:

1. Intervention Group - Medical Yoga, group treatment for eight weeks, 60 minutes per week, with the guidance of a physical therapist.

or

2. Control - treatment as usual (TAU) in physical therapy.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-09
• Study First Submitted: 2016-09-09
• Study First Submitted QC: 2016-09-19
• Study First Posted: 2016-09-20
• Primary Completion: 2019-02-15
• Study Completion: 2019-03-04
• Status Verified: 2020-09
• Last Update Submitted: 2020-09-13
• Last Update Posted: 2020-09-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

• Perceived stress and anxiety, which could be expressed as for example as tension in the neck and shoulders, insomnia, anxiety and headaches.

Exclusion Criteria

• Do not understand Swedish (as group instructions need to be understood),
• Pregnancy,
• Psychotic symptoms,
• Ongoing or physical therapy treatment the last three months,
• Previously participated in Medical Yoga group.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Medical Yoga	Medical Yoga	Medical Yoga Group therapy for eight weeks, 60 minutes per week, with the guidance of a physical therapist.
Treatment as Usual (physical therapy)	Treatment as Usual (physical therapy)	Treatment as Usual provided by physical therapist

Primary Outcome Measures

Name	Time	Method
Perceived Stress Scale (PSS)	baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session	Outcome will be measured as change between baseline and follow-ups and between follow-ups. Total score will also be analysed between groups at follow-up(s).

Secondary Outcome Measures

Name	Time	Method
Health-related quality of Life; EQ5D	baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Thorax excursion: Measured in centimeters with tape measure, chest size at the level of processus xiphoideus, the difference between the maximum inhalation and exhalation is registered	baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Hospital Anxiety and Depression Scale (HADS)	baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Health-related quality of Life; EQ-VAS	baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session

Trial Locations

Locations (1)

Narhalsan Gibraltar rehabmottagning; 🇸🇪 Gothenburg, Sweden